Evidence map›Paper›PMID 25628358›Full record

ArticleNucleic acids research2015

Human regulator of telomere elongation helicase 1 (RTEL1) is required for the nuclear and cytoplasmic trafficking of pre-U2 RNA.

Michael Schertzer, Karina Jouravleva, Mylene Perderiset, Florent Dingli, Damarys Loew, Tangui Le Guen, Barbara Bardoni, Jean-Pierre de Villartay, Patrick Revy, Arturo Londoño-Vallejo

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Molecular mechanisms of telomere biology disorders.The Journal of biological chemistry
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Michael SchertzerTelomeres & Cancer laboratory, CNRS, 'Labellisé Ligue', Institut Curie, 26 rue d'Ulm, Paris 75248, France Sorbonne Universités, Paris 06, Paris F-75005, France PSL Research University, Paris, France.
Karina JouravlevaTelomeres & Cancer laboratory, CNRS, 'Labellisé Ligue', Institut Curie, 26 rue d'Ulm, Paris 75248, France Sorbonne Universités, Paris 06, Paris F-75005, France PSL Research University, Paris, France.
Mylene PerderisetTelomeres & Cancer laboratory, CNRS, 'Labellisé Ligue', Institut Curie, 26 rue d'Ulm, Paris 75248, France Sorbonne Universités, Paris 06, Paris F-75005, France PSL Research University, Paris, France.
Florent DingliLaboratory of Proteomic Mass Spectrometry, Institut Curie, Paris, France.
Damarys LoewLaboratory of Proteomic Mass Spectrometry, Institut Curie, Paris, France.
Tangui Le GuenINSERM UMR 1163, Laboratory of Genome Dynamics in the Immune System, Paris, France Université Sorbonne Paris Cité, Université Paris Descartes, Institut Imagine, Paris, France.
Barbara BardoniIPMC-CNRS UMR7275-Valbonne, France Université de Nice Sophia-Antipolis, Nice 06560, France.
Jean-Pierre de VillartayINSERM UMR 1163, Laboratory of Genome Dynamics in the Immune System, Paris, France Université Sorbonne Paris Cité, Université Paris Descartes, Institut Imagine, Paris, France.
Patrick RevyINSERM UMR 1163, Laboratory of Genome Dynamics in the Immune System, Paris, France Université Sorbonne Paris Cité, Université Paris Descartes, Institut Imagine, Paris, France.
Arturo Londoño-VallejoTelomeres & Cancer laboratory, CNRS, 'Labellisé Ligue', Institut Curie, 26 rue d'Ulm, Paris 75248, France Sorbonne Universités, Paris 06, Paris F-75005, France PSL Research University, Paris, France Arturo.Londono@curie.fr.
Centre National de la Recherche Scientifique · FRInstitut Curie · FRSorbonne Université · FRInserm · FRSorbonne Paris Cité · FRUniversité Côte d'Azur · FRUniversité Paris Sciences et Lettres · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hoyeraal-Hreidarsson syndrome (HHS) is a severe form of Dyskeratosis congenita characterized by developmental defects, bone marrow failure and immunodeficiency and has been associated with telomere dysfunction. Recently, mutations in Regulator of Telomere ELongation helicase 1 (RTEL1), a helicase first identified in Mus musculus as being responsible for the maintenance of long telomeres, have been identified in several HHS patients. Here we show that RTEL1 is required for the export and the correct cytoplasmic trafficking of the small nuclear (sn) RNA pre-U2, a component of the major spliceosome complex. RTEL1-HHS cells show abnormal subcellular partitioning of pre-U2, defects in the recycling of ribonucleotide proteins (RNP) in the cytoplasm and splicing defects. While most of these phenotypes can be suppressed by re-expressing the wild-type protein in RTEL1-HHS cells, expression of RTEL1 mutated variants in immortalized cells provokes cytoplasmic mislocalizations of pre-U2 and other RNP components, as well as splicing defects, thus phenocopying RTEL1-HHS cellular defects. Strikingly, expression of a cytoplasmic form of RTEL1 is sufficient to correct RNP mislocalizations both in RTEL1-HHS cells and in cells expressing nuclear mutated forms of RTEL1. This work unravels completely unanticipated roles for RTEL1 in RNP trafficking and strongly suggests that defects in RNP biogenesis pathways contribute to the pathology of HHS.

Indexed as

Base SequenceBiological TransportBlotting, NorthernCell NucleusChromatography, LiquidCytoplasmDNA HelicasesDNA PrimersHEK293 CellsHeLa CellsHumansPolymerase Chain ReactionRNA PrecursorsRNA, Small InterferingRNA, Small NuclearTandem Mass SpectrometryDNA HelicasesDNA PrimersRNA PrecursorsRNA, Small InterferingRNA, Small NuclearRTEL1 protein, humanU2 small nuclear RNA

Identifiers

PMID25628358
PMCPMC4330364
OpenAlexW2149015153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.